Increased immunogenicity of HIV envelope subunit complexed with α2-macroglobulin when combined with monophosphoryl lipid A and GM-CSF

Vaccine

Volumn 20, Issue 17-18, 2002, Pages 2396-2403

  Liao, Hua Xin ^a   Cianciolo, George J ^a   Staats, Herman F ^a   Scearce, Richard M ^a   Lapple, Dana M ^a   Stauffer, Stephen H ^a   Thomasch, James R ^a   Pizzo, Salvatore V ^a   Montefiori, David C ^b   Hagen, Michael ^c   Eldridge, John ^c   Haynes, Barton F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Wyeth Lederle Vaccines   (United States)

Author keywords

AIDS; Antigen presentation processing; Antigen peptides epitopes; Cytokines; Vaccination

Indexed keywords

ALPHA 2 MACROGLOBULIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PHOSPHORYL LIPID A;

ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; EVALUATION; FEMALE; GRANULOCYTE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; MACROPHAGE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ALPHA-MACROGLOBULINS; AMINO ACID SEQUENCE; ANIMALS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; LIPID A; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; VACCINES, SYNTHETIC;

EID: 0037157236     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00090-7     Document Type: Article

References (31)

1. HIV vaccines: Where we and where we are going
2. Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes
3. HIV type 1 V3 region primer-induced antibody suppression is overcome by administration of C4-V3 peptides as a polyvalent immunogen
4. The adjuvant activity of monophosphoryl lipid A
5. Safety immunogenicity and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine
6. Safety immunogenicity and efficacy of Plasmodium falciparum repeatless circumsporozoite protein vaccine encapsulated in liposomes
7. Evaluation of the safety reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults
8. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria RTS S malaria vaccine evaluation group
9. Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: Granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytotoxic T lymphocytes
10. Granulocyte-macrophage colony-stimulating factor: An effective adjuvant for protein and peptide-based vaccines
11. Adjuvant-free in vivo targeting antigen delivery by alpha 2-macroglobulin enhances antibody formation
12. Receptor-mediated antigen delivery into macrophages complexing antigen to alpha 2-macroglobulin enhances presentation to T-cells
13. Adjuvant of alpha 2-macroglobulin an independent ligand for the heat shock protein receptor CD91
14. 2-macroglobulin: Evidence for dramatically-increased immunogenicity
15. 2-macroglobulin
16. 2-macroglobulin
17. Complete nucleotide sequence of the AIDS virus HTLV-III
18. Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys
19. Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide
20. Enzyme-linked immunosorbent assay elisa 3 quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes
21. Induction of antibodies against HIV envelope that neutralize non-pathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains
22. Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a SHIV expressing a primary patient HIV-1 isolate envelope
23. Constitutive competition by self proteins for antigen presentation can be overcome by receptor-enhanced uptake
24. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones
25. Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes
26. Structures and functions of multilig and lipoprotein receptors: Macrophage scavenger receptors and LDL receptor-related protein (LRP)
27. NMR-derived solution conformations of a hybrid synthetic peptide containing multiple epitopes of envelope protein gp120 from the RF strain of human immunodeficiency virus
28. Conformational preferences of a chimeric peptide HIV-I immunogen from the C4-V3 domains of gp120 envelope protein of HIV-I CANOA based on solution NMR: Comparison to a related immunogenic peptide from HIV-I RF
29. QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans